Related Experiment Video
Updated: Jan 8, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Nek2 kinase in chromosome instability and cancer
Daniel G Hayward1, Andrew M Fry
1Department of Biochemistry, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK.
Abstract:
Aneuploidy and chromosome instability are two of the most common abnormalities in cancer cells. They arise through defects in cell division and, specifically, in the unequal segregation of chromosomes between daughter cells during mitosis. A number of cell cycle dependent protein kinases have been identified that control mitotic progression and chromosome segregation. Some of these localize to the centrosome and regulate mitotic spindle formation. One such protein is Nek2, a member of the NIMA-related serine/threonine kinase family. Data are emerging that Nek2 is abnormally expressed in a wide variety of human cancers. In this review, we summarize current knowledge on the expression, regulation and function of Nek2, consider how Nek2 may contribute to chromosome instability, and ask whether it might make an attractive target for chemotherapeutic intervention in human cancer.
Insights
Nek2, a protein kinase involved in cell division, is often abnormally expressed in cancers. Understanding Nek2
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Aneuploidy and chromosome instability are hallmarks of cancer, stemming from errors in mitosis and chromosome segregation.
- Cell cycle-dependent protein kinases regulate mitosis and centrosome function, impacting chromosome stability.
- Nek2, a serine/threonine kinase, is implicated in centrosome regulation and mitotic progression.
Purpose of the Study:
- To review current knowledge on Nek2 expression, regulation, and function in cancer.
- To explore Nek2's potential role in driving chromosome instability.
- To assess Nek2 as a potential therapeutic target for cancer treatment.
Main Methods:
- Literature review of existing studies on Nek2 in cancer.
- Analysis of data on Nek2 expression and function.
- Discussion of Nek2's role in mitotic regulation and potential therapeutic implications.
Main Results:
- Nek2 is aberrantly expressed across numerous human cancers.
- Nek2 plays a role in centrosome function and mitotic spindle formation.
- Emerging data suggest Nek2 contributes to chromosome instability.
Conclusions:
- Nek2 is frequently overexpressed in human cancers.
- Nek2's functions in mitosis suggest a role in cancer development and progression.
- Nek2 represents a promising therapeutic target for novel cancer interventions.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Inhibition of Cdk Activity

